Two Sigma Advisers
BHVN icon

Two Sigma Advisers’s Biohaven BHVN Stock Holding History

Two Sigma Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-358,700
Closed -$4.05M – 279
2025
Q4 		$4.05M Buy
358,700
+145,900
+69% +$1.81M 0.01% 911
2025
Q3 		$3.19M Buy
+212,800
New +$3.1M 0.01% 922
2025
Q2 		– Sell
-31,400
Closed -$755K – 2331
2025
Q1 		$755K Sell
31,400
-68,500
-69% -$2.42M ﹤0.01% 1598
2024
Q4 		$3.73M Sell
99,900
-84,300
-46% -$3.93M 0.01% 836
2024
Q3 		$9.2M Buy
184,200
+10,900
+6% +$424K 0.02% 511
2024
Q2 		$6.02M Buy
173,300
+55,800
+47% +$2.21M 0.01% 695
2024
Q1 		$6.43M Sell
117,500
-28,700
-20% -$1.42M 0.01% 681
2023
Q4 		$6.26M Buy
+146,200
New +$4.55M 0.01% 714

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers's BHVN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 358,700 shares — an estimated $4.05M sold.

Two Sigma Advisers first reported a position in BHVN in Q4 2023 and held it in 8 quarters. The position peaked at $9.2M in Q3 2024. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 358,700 Biohaven shares in Q1 2026, an estimated $4.05M.
  • Two Sigma Advisers first reported a position in Biohaven in Q4 2023 and held it in 8 quarters.
  • Two Sigma Advisers's Biohaven position peaked at $9.2M in Q3 2024.
  • 276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.